Blood Platelets Market Trends

  • Report ID: 4719
  • Published Date: Sep 10, 2025
  • Report Format: PDF, PPT

Blood Platelets Market Growth Drivers and Challenges:

Growth Drivers

  • Increasing Geriatric Population – The aging population is more prone to conditions requiring platelet transfusion such as cancer, cardiovascular disease, and chronic liver disease. As the global population ages, the demand for blood platelets is anticipated to grow due to the high prevalence of age-related health issues.
  • Growing Prevalence of Blood-Related Disorder - With the growing prevalence of chronic blood disorders such as hemophilia, myelofibrosis, and thrombocytopenia, the demand for platelets is growing. As these conditions demand regular platelet transfusion to manage bleeding episodes. Around 324,648 out of 5.5 billion people worldwide have an identified bleeding disorder, reported as by the World Federation of Hemophilia's 2019 annual global survey. 
  • Surge in Number of Surgical Procedures - The increasing number of surgical procedures worldwide also contributes to the increased need for blood platelets. The increase in orthopedic and cardiac surgeries has increased the need for platelets in hospitals. In addition, increased organ transplantation such as kidney, corneal implants, and others has increased the demand for platelets. Recorded by World Observatory on Donations and Transplants, 153,863 organs were transplanted annually in 2019, which is an increase of 4.8% from 2018. 

Challenges

  • High Risk Related to the Transmission of Infections - Blood transfusions comprise significant health risks. Among these, transmission of infectious organisms remains one of the most concerning complications. Hepatitis B used to be the biggest transfusion risk. Also, there may be a chance of wrong blood group typing while transferring the blood to the patients. However, unnecessary blood transfusions should be avoided to reduce the risk of infection and other complications.  
  • High Treatment Cost Associated
  • Shortage of Blood Donors

Base Year

2025

Forecast Period

2026-2035

CAGR

4.8%

Base Year Market Size (2025)

USD 5.71 billion

Forecast Year Market Size (2035)

USD 9.13 billion

Regional Scope

  • North America (U.S. and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, South Korea, Malaysia, Australia, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of blood platelets is estimated at USD 5.96 billion.

The global blood platelets market size was more than USD 5.71 billion in 2025 and is anticipated to grow at a CAGR of more than 4.8%, reaching USD 9.13 billion revenue by 2035.

North America blood platelets market will hold over 35% share by 2035, driven by increased demand for blood transfusion, rising number of accidents, and economic growth boosting healthcare spending.

Key players in the market include Aggredyne Inc., Sysmex Corporation, Haemochrom Diagnostics GmbH, Eurobio Scientific, LABiTec Labor BioMedical Technologies GmbH, Thermo Fisher Scientific Inc., PerkinElimer Inc., Werfen, S.A., F. Hoffmann-La Roche Ltd., Terumo Corporation.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos